Second-generation antipsychotics offer mixed results: Finding most effective antipsychotic drug can be trial and error process

Antipsychotics are the fourth largest group of medications prescribed in the United States today, with a collective cost of approximately $10 billion. Newer, second-generation medications represent 90% of the current market, and they cost considerably more than older antipsychotics.